Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

IDEAYA Biosciences

Market Cap: US$2.9b

A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

Cipher Pharmaceuticals

Market Cap: CA$372.2m

Operates as a specialty pharmaceutical company in Canada.

Oncoinvent

Market Cap: NOK 210.5m

A clinical stage company, develops radiopharmaceutical therapies against cancer.

Gerresheimer

Market Cap: €931.2m

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Galderma Group

Market Cap: CHF 38.6b

Operates as a dermatology company worldwide.

Thor Medical

Market Cap: NOK 1.6b

Produces and supplies alpha-particle emitters for cancer therapy in Norway.

Exact Sciences

Market Cap: US$19.3b

Provides cancer screening and diagnostic test products in the United States and internationally.

MoonLake Immunotherapeutics

Market Cap: US$955.7m

A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

WEED

Market Cap: US$9.9m

Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.

Nuvation Bio

Market Cap: US$3.2b

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

Hyperion DeFi

Market Cap: US$30.0m

An ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.

Vistagen Therapeutics

Market Cap: US$30.7m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders.

Memphis Pharmaceuticals & Chemical Industries

Market Cap: ج.م3.6b

A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.

JBM (Healthcare)

Market Cap: HK$2.1b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

aTyr Pharma

Market Cap: US$73.5m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

Eton Pharmaceuticals

Market Cap: US$439.0m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

OmniAb

Market Cap: US$300.9m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

MapLight Therapeutics

Market Cap: US$896.8m

Operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.

OSR Holdings

Market Cap: US$16.7m

A healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea.

Sensorion

Market Cap: €98.6m

A biotechnology company, develops drug candidates for the treatment of inner ear disorders in France.

Kiora Pharmaceuticals

Market Cap: US$7.9m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.

Sartorius Stedim Biotech

Market Cap: €19.9b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Light AI

Market Cap: CA$16.9m

A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.

Pacific Edge

Market Cap: NZ$168.7m

A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.

Talphera

Market Cap: US$51.3m

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.

Beta Drugs

Market Cap: ₹15.4b

Develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India.

Rimrock Gold

Market Cap: US$1.0m

Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.

Hero Technologies

Market Cap: US$56.4k

Operates as an early-stage cannabis company.

Blue Jet Healthcare

Market Cap: ₹92.2b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

Hansoh Pharmaceutical Group

Market Cap: HK$233.1b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Astellas Pharma

Market Cap: JP¥3.8t

Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.

Emcure Pharmaceuticals

Market Cap: ₹262.5b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Ajanta Pharma

Market Cap: ₹328.8b

A pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Neimeth International Pharmaceuticals

Market Cap: ₦26.3b

Manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana.

Imugene

Market Cap: AU$96.2m

A clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.